Results 191 to 200 of about 237,935 (242)

EMAS clinical guide: Low-dose vaginal estrogens for postmenopausal vaginal atrophy

Maturitas, 2012
Vaginal atrophy is common in postmenopausal women. This clinical guide provides the evidence for the clinical use of vaginal estrogens for this condition focussing on publications since the 2006 Cochrane systematic review. Use after breast cancer, before
Herman Depypere, Tommaso Simoncini
exaly   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

The Detection and Management of Vaginal Atrophy

Journal of Obstetrics and Gynaecology Canada, 2004
To support the practitioner in the diagnosis of vaginal atrophy and in the management of the related symptoms.The modalities of evaluation range from basic pelvic examination, examination of the vulva, and laboratory tests.A comprehensive approach to the detection of vaginal atrophy and a discussion of available therapeutic and nontherapeutic options ...
Shawna L, Johnston, Scott A, Farrell, Celine, Bouchard, Scott A, Farrell, Lo-Ann, Beckerson, Margery, Comeau, Shawna L, Johnston, Guylaine, Lefebvre, Alexandra, Papaioannou   +8 more
  +5 more sources

Postpartum vaginal atrophy

American Journal of Obstetrics and Gynecology, 1991
Postpartum vaginal atrophy has been briefly noted without adequate clinical description. We present a study of 215 puerperas at a scheduled 4-week postpartum visit, investigating colorpHast vaginal pH, vestibular cotton swab testing, vaginal wall tenderness, and both fixed and wet mount cytologic studies.
P M, Wisniewski, E J, Wilkinson
openaire   +2 more sources

Postmenopausal Vaginal Atrophy and Atrophic Vaginitis

The American Journal of the Medical Sciences, 1997
Menopause is associated with a marked reduction in endogenous estrogen production. Lower levels of circulating blood estrogen have various deleterious effects, including those on the lower urinary tract. The vaginal epithelium becomes atrophied and dry, which can cause vaginal discomfort, itching, and dyspareunia. The epithelium may become inflamed and
L, Pandit, J G, Ouslander
openaire   +2 more sources

Materials Selection for the Injection into Vaginal Wall for Treatment of Vaginal Atrophy

Aesthetic Plastic Surgery, 2021
Vaginal atrophy caused by the aging process and perineal trauma has a negative impact on women. A new vaginal atrophy treatment is injection of materials into the vaginal wall, including platelet-rich plasma (PRP), autogenous fat graft (AFG), hyaluronic acid (HA), botulinum toxin (BTX), and collagen, but to date their efficacy has not been reviewed ...
Zhifang, Zheng, Junfeiyang, Yin, Biao, Cheng, Wenhua, Huang   +3 more
openaire   +2 more sources

Effective treatment of vaginal atrophy with isoflavone vaginal gel

Maturitas, 2013
To assess efficacy and tolerability of a isoflavone (Glycine max L. Merr.) vaginal gel to the treatment of vaginal atrophy in postmenopausal women.The double-blind, randomized, placebo-controlled, clinical trial. Ninety women were treated for 12 weeks with isoflavone vaginal gel 4% (1g/day) and a placebo gel and conjugated equine estrogen cream (0.3mg ...
Sonia M Rolim Rosa, Lima, Silvia Saito, Yamada, Benedito Fabiano, Reis, Sostenes, Postigo, Maria Antonieta L, Galvão da Silva, Tsutomu, Aoki   +5 more
openaire   +2 more sources

Management of post-menopausal vaginal atrophy and atrophic vaginitis

Maturitas, 2005
The involution of the female genital tract seems to reflect a built-in biological life expectancy, inter-related with the hypothalamic-hypophyseal-ovarian axis. Lower levels of oestradiol have a number of adverse effects, including on the lower urinary tract. The major universal change is vaginal atrophy.
Camil, Castelo-Branco, Maria Jesús, Cancelo, Jose, Villero, Francisco, Nohales, Maria Dolores, Juliá   +4 more
openaire   +2 more sources

Newly developed vaginal atrophy symptoms II and vaginal pH: a better correlation in vaginal atrophy?

Climacteric, 2014
The primary objective of this study was to evaluate the correlation among symptoms, signs, and the number of lactobacilli in postmenopausal vaginal atrophy. The secondary objective was to develop a new parameter to improve the correlation.A cross-sectional descriptive study.Naturally postmenopausal women aged 45-70 years with at least one clinical ...
P, Tuntiviriyapun, K, Panyakhamlerd, S, Triratanachat, T, Chatsuwan, S, Chaikittisilpa, U, Jaisamrarn, N, Taechakraichana   +6 more
openaire   +2 more sources

Emerging therapies for postmenopausal vaginal atrophy

Maturitas, 2013
Symptoms related to vaginal atrophy are a significant problem for postmenopausal women and estrogen has been the gold standard for its treatment. A number of recent reviews of vaginal estrogen products are available. This review will, therefore, focus on other products and potential products for this indication, including the tissue selective estrogen ...
openaire   +2 more sources

Vaginal Estrogen Preparations: A Review of Safety and Efficacy for Vaginal Atrophy

Journal of Women's Health, 2002
A theoretical advantage of local (i.e., vaginal) therapy of genitourinary symptoms could be avoidance of systemic adverse effects. Review of efficacy and adverse effects of commonly prescribed vaginal estrogens is of great clinical relevance.A Medline (1966-present) search was performed for randomized controlled trials involving vaginal estrogens ...
openaire   +2 more sources